CS258136B2 - Method of new 6-fluoro-7(pyrrol-1-yl)-1-cyclopropyl-1,4--dihydro-4-oxoquinoline-3-carboxyl acid production - Google Patents
Method of new 6-fluoro-7(pyrrol-1-yl)-1-cyclopropyl-1,4--dihydro-4-oxoquinoline-3-carboxyl acid production Download PDFInfo
- Publication number
- CS258136B2 CS258136B2 CS859213A CS921385A CS258136B2 CS 258136 B2 CS258136 B2 CS 258136B2 CS 859213 A CS859213 A CS 859213A CS 921385 A CS921385 A CS 921385A CS 258136 B2 CS258136 B2 CS 258136B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- pyrrol
- cyclopropyl
- dihydro
- fluoro
- atcc
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 9
- 239000002253 acid Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 claims description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 3
- -1 alkaline earth metal salt Chemical class 0.000 claims description 3
- 239000012312 sodium hydride Substances 0.000 claims description 3
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 3
- ISJRMOARTUIEPA-UHFFFAOYSA-N 1-cyclopropyl-6-fluoro-4-oxo-7-pyrrol-1-ylquinoline-3-carboxylic acid Chemical compound C12=CC(N3C=CC=C3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 ISJRMOARTUIEPA-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 2
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 2
- 238000005904 alkaline hydrolysis reaction Methods 0.000 claims description 2
- 230000020477 pH reduction Effects 0.000 claims description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 14
- 239000000203 mixture Substances 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000002609 medium Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 244000005700 microbiome Species 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical class C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 229960000210 nalidixic acid Drugs 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- KHLJKXMEOWXGMX-UHFFFAOYSA-N 2,5-difluoro-4-pyrrol-1-ylbenzoic acid Chemical compound C1=C(F)C(C(=O)O)=CC(F)=C1N1C=CC=C1 KHLJKXMEOWXGMX-UHFFFAOYSA-N 0.000 description 2
- JSCKHMBCZNAFOJ-UHFFFAOYSA-N 2,5-difluoro-4-pyrrol-1-ylbenzoyl chloride Chemical compound C1=C(C(Cl)=O)C(F)=CC(N2C=CC=C2)=C1F JSCKHMBCZNAFOJ-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102100039814 E3 ubiquitin-protein ligase RNF170 Human genes 0.000 description 2
- 101000667666 Homo sapiens E3 ubiquitin-protein ligase RNF170 Proteins 0.000 description 2
- 241000588915 Klebsiella aerogenes Species 0.000 description 2
- 241000191938 Micrococcus luteus Species 0.000 description 2
- 241000607715 Serratia marcescens Species 0.000 description 2
- 241000607768 Shigella Species 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229940092559 enterobacter aerogenes Drugs 0.000 description 2
- BNRAJXHGLPYUCS-UHFFFAOYSA-N ethyl 3-(2,5-difluoro-4-pyrrol-1-ylphenyl)-3-oxopropanoate Chemical compound C1=C(F)C(C(=O)CC(=O)OCC)=CC(F)=C1N1C=CC=C1 BNRAJXHGLPYUCS-UHFFFAOYSA-N 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- GFISDBXSWQMOND-UHFFFAOYSA-N 2,5-dimethoxyoxolane Chemical compound COC1CCC(OC)O1 GFISDBXSWQMOND-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- YOXMTBAQSNCVJQ-UHFFFAOYSA-N 4-amino-2,5-difluorobenzoic acid Chemical compound NC1=CC(F)=C(C(O)=O)C=C1F YOXMTBAQSNCVJQ-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- 241000588919 Citrobacter freundii Species 0.000 description 1
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000515012 Micrococcus flavus Species 0.000 description 1
- 241000588772 Morganella morganii Species 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 102220452443 c.137T>A Human genes 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- GIHUTIWNZGUMJH-UHFFFAOYSA-N ethyl 1-cyclopropyl-6-fluoro-4-oxo-7-pyrrol-1-ylquinoline-3-carboxylate Chemical compound C12=CC(N3C=CC=C3)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1CC1 GIHUTIWNZGUMJH-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000002044 hexane fraction Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8419001A FR2574404B1 (fr) | 1984-12-12 | 1984-12-12 | Derives 1-substitues de l'acide 6-fluoro-7-(pyrrol-1-yl)-1,4-dihydro-4-oxoquinoleine-3-carboxylique, leur preparation et leur application en tant que medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
CS921385A2 CS921385A2 (en) | 1987-12-17 |
CS258136B2 true CS258136B2 (en) | 1988-07-15 |
Family
ID=9310528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS859213A CS258136B2 (en) | 1984-12-12 | 1985-12-12 | Method of new 6-fluoro-7(pyrrol-1-yl)-1-cyclopropyl-1,4--dihydro-4-oxoquinoline-3-carboxyl acid production |
Country Status (15)
Country | Link |
---|---|
US (1) | US4727080A (ro) |
EP (1) | EP0187085B1 (ro) |
JP (1) | JPS61197577A (ro) |
AT (1) | ATE56446T1 (ro) |
CS (1) | CS258136B2 (ro) |
DD (1) | DD242042A5 (ro) |
DE (1) | DE3579683D1 (ro) |
ES (1) | ES8704930A1 (ro) |
FR (1) | FR2574404B1 (ro) |
HU (1) | HU195802B (ro) |
PL (1) | PL146541B1 (ro) |
PT (1) | PT81652B (ro) |
RO (1) | RO93482B (ro) |
SU (1) | SU1426453A3 (ro) |
YU (1) | YU43691B (ro) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3519286A1 (de) * | 1985-05-30 | 1986-12-04 | Bayer Ag, 5090 Leverkusen | 7-azolyl-1-cyclopropyl-1,4-dihydro-4-oxo-3- chinolincarbonsaeuren und -1,8-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
DE3606698A1 (de) * | 1986-03-01 | 1987-09-03 | Bayer Ag | 7-(1-pyrrolidinyl)-chinoloncarbonsaeure -derivate |
US5153204A (en) * | 1986-03-01 | 1992-10-06 | Bayer Aktiengesellschaft | 7-(1-Pyrrolidinyl)-quinolonecarboxylic acid derivatives |
DE3639465A1 (de) * | 1986-11-18 | 1988-05-19 | Hoechst Ag | Optisch aktive gyrasehemmer, ihre herstellung und verwendung als antibiotika |
FR2629456B1 (fr) * | 1988-03-31 | 1991-07-05 | Esteve Labor Dr | Derives des acides 7-(1-imidazolyl),1,4-dihydro-4-oxo-6,8-difluoro-1-cyclopropyl-3-quinoleincarboxylique, leur preparation et leur application en tant que medicaments |
US5233091A (en) * | 1988-06-21 | 1993-08-03 | Pfizer Inc. | 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor |
US5103040A (en) * | 1988-06-21 | 1992-04-07 | Pfizer Inc. | 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor |
US5039682A (en) * | 1988-06-21 | 1991-08-13 | Pfizer Inc. | 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor |
US5104868A (en) * | 1988-06-21 | 1992-04-14 | Pfizer Inc. | Tricyclic derivatives of 7-substituted-6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acids and esters |
CA2058424A1 (en) * | 1989-07-21 | 1991-01-22 | Akihiro Shibata | Quinoline carboxylic acid derivatives |
WO2005019224A2 (en) * | 2003-06-06 | 2005-03-03 | Cadila Healthcare Limited | Novel antiinfective compounds |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1175836A (en) * | 1977-09-20 | 1984-10-09 | Marcel Pesson | Production of 1,4-dihydroquinoline-3-carboxylic acid derivatives |
DE3142854A1 (de) * | 1981-10-29 | 1983-05-11 | Bayer Ag, 5090 Leverkusen | 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
SE440354B (sv) * | 1981-02-19 | 1985-07-29 | Kyorin Seiyaku Kk | Kinolinkarboxylsyraderivat |
US4499091A (en) * | 1982-03-31 | 1985-02-12 | Sterling Drug Inc. | 1-Amino (or substituted amino)-1,4-dihydro-4-oxo-6-fluoro-7-heterylquinoline-3-carboxylic acids and their use as antibacterial agents |
DE3248507A1 (de) * | 1982-12-29 | 1984-07-05 | Bayer Ag, 5090 Leverkusen | Mikrobizide mittel auf chinoloncarbonsaeure basis |
FR2559484B2 (fr) * | 1983-07-06 | 1986-09-26 | Provesan Sa | Nouveau derive 7-(pyrrol-1-yl) de l'acide 1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridin)-3-carboxylique, sa preparation et son application en tant que medicament |
IT1221492B (it) * | 1984-03-13 | 1990-07-06 | Biochem Design Srl | Acidi 7-(1-pirril)-e 7-(1-pirroli-dinil)-6-fluoro-1-etil-1,4-diidro-4-chetochinolin-3-carbossilici ad attivita' antimicrobiche,loro procedimento di preparazione e composti farmaceutici che li contengono |
US4571396A (en) * | 1984-04-16 | 1986-02-18 | Warner-Lambert Company | Antibacterial agents |
US4636506A (en) * | 1984-12-06 | 1987-01-13 | Pfizer, Inc. | 7-heterocyclic-1,4-dihydroquinolones |
-
1984
- 1984-12-12 FR FR8419001A patent/FR2574404B1/fr not_active Expired
-
1985
- 1985-12-09 US US06/806,695 patent/US4727080A/en not_active Expired - Fee Related
- 1985-12-10 RO RO121090A patent/RO93482B/ro unknown
- 1985-12-10 AT AT85402450T patent/ATE56446T1/de not_active IP Right Cessation
- 1985-12-10 EP EP85402450A patent/EP0187085B1/fr not_active Expired - Lifetime
- 1985-12-10 DE DE8585402450T patent/DE3579683D1/de not_active Expired - Fee Related
- 1985-12-11 YU YU1923/85A patent/YU43691B/xx unknown
- 1985-12-11 JP JP60277054A patent/JPS61197577A/ja active Granted
- 1985-12-11 SU SU853991041A patent/SU1426453A3/ru active
- 1985-12-11 DD DD85284140A patent/DD242042A5/de not_active IP Right Cessation
- 1985-12-11 PT PT81652A patent/PT81652B/pt unknown
- 1985-12-12 PL PL1985256757A patent/PL146541B1/pl unknown
- 1985-12-12 ES ES550689A patent/ES8704930A1/es not_active Expired
- 1985-12-12 HU HU854757A patent/HU195802B/hu not_active IP Right Cessation
- 1985-12-12 CS CS859213A patent/CS258136B2/cs unknown
Also Published As
Publication number | Publication date |
---|---|
HUT40640A (en) | 1987-01-28 |
HU195802B (en) | 1988-07-28 |
JPS61197577A (ja) | 1986-09-01 |
PL256757A1 (en) | 1986-10-07 |
PT81652B (pt) | 1988-04-21 |
FR2574404B1 (fr) | 1987-04-24 |
PT81652A (fr) | 1986-01-01 |
FR2574404A1 (fr) | 1986-06-13 |
ES550689A0 (es) | 1987-05-01 |
RO93482B (ro) | 1988-01-02 |
PL146541B1 (en) | 1989-02-28 |
YU192385A (en) | 1988-04-30 |
EP0187085B1 (fr) | 1990-09-12 |
SU1426453A3 (ru) | 1988-09-23 |
DD242042A5 (de) | 1987-01-14 |
ATE56446T1 (de) | 1990-09-15 |
ES8704930A1 (es) | 1987-05-01 |
YU43691B (en) | 1989-10-31 |
EP0187085A1 (fr) | 1986-07-09 |
JPH0312064B2 (ro) | 1991-02-19 |
CS921385A2 (en) | 1987-12-17 |
US4727080A (en) | 1988-02-23 |
RO93482A (ro) | 1987-12-31 |
DE3579683D1 (de) | 1990-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4886810A (en) | Quinoline derivatives, pharmaceutical composition and method of use | |
Chu et al. | Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents | |
SU1598873A3 (ru) | Способ получени производных хинолина или их фармацевтически приемлемых сложных эфиров или фармацевтически приемлемых аддитивных солей кислоты | |
FR2555584A1 (fr) | Derives de l'acide fluoro-6-dihydro-1,4-oxo-4-piperazinyl substitue-7-quinoline-carboxylique-3 et procede pour leur preparation et compositions pharmaceutiques a action anti-bacteriennes a base desdits derives | |
JPH0813811B2 (ja) | 7―(1―アセチジニル)―1、4―ジヒドロ―4―オキソキノリン―3―カルボン酸の誘導体、その製造法、およびその医薬としての用途 | |
CS258136B2 (en) | Method of new 6-fluoro-7(pyrrol-1-yl)-1-cyclopropyl-1,4--dihydro-4-oxoquinoline-3-carboxyl acid production | |
DD204919A5 (de) | Verfahren zur herstellung von (4-oxo-4h-1-benzopyran-8-yl)-alkancarbonsaeuren und deren alkalimetallsalzen, estern, aminoestern und amiden | |
US4559342A (en) | Quinolone acids and antibacterial agents containing these compounds | |
US4552882A (en) | 7-(1-Pyrrolyl) derivatives of 1-ethyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids and 1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids and their use as antimicrobial agents | |
US4382937A (en) | Naphthyridine derivatives and their use as anti-bacterials | |
US4711892A (en) | Certain 5-nitro-2-furyl derivatives of pyridylpropenoic acid hydrazides which are useful in treating bacterial, fungal, protozoal, parasitic and intestinal infections | |
EP0181521A1 (en) | Antimicrobial 1-substituted Phenyl-4-oxoquinoline-3-carboxylic acid compounds | |
KR930006774B1 (ko) | 퀴놀린 유도체 | |
JP2655691B2 (ja) | ナフチリジン抗嫌気菌用化合物 | |
JPS6339880A (ja) | 新規な1,8−橋状結合された4−キノロンカルボン酸類およびこれらを含有している薬品類 | |
US4971970A (en) | Benzoheterocyclic compounds | |
US4348521A (en) | Substituted pyridoquinoxaline-6-carboxylic acids and derivatives thereof | |
JP2598929B2 (ja) | 新規ピリドンカルボン酸誘導体、そのエステルおよびその塩 | |
US4499270A (en) | Substituted pyridoquinoxaline-6-carboxylic acids and derivatives thereof | |
JPH0720941B2 (ja) | 新規キノロン誘導体、そのエステルおよびその塩 | |
JPH026756B2 (ro) | ||
JP2621292B2 (ja) | 抗菌化合物 | |
KR890000863B1 (ko) | 퀴날딘 유도체 | |
EP0340055B1 (fr) | Dérivés de l'acide 7-(1-imidazolyl)-1,4-dihydro-4-oxo-6,8-difluoro-1-cyclopropyl-3-quinoléincarboxylique, leur préparation et leur application en tant que médicaments | |
DE3200427A1 (de) | Neue organische verbindung, verfahren zu ihrer herstellung und ihre verwendung |